As COVID-19 continues to affect the global populace, the diagnosis of the novel coronavirus for speedy recovery has become the need of the hour. Therefore, the COVID-19 pandemic may prove to be a growth accelerator for the viral disease diagnosis market. Viruses, including coronaviruses are tiny organisms made up of genetic material–either DNA or RNA. Viral disease diagnosis is significant to alleviate the pandemic risk. The diagnosis helps in identifying the viral pathogens to monitor and apply necessary therapy for treatment and to prevent further transmission of the disease.
Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=62
Novel technologies springing up for speedy COVID-19 diagnosis
To enable speedy of COVID-19 testing, assay manufacturers and researchers are coming up with numerous new techniques. For instance, South Korea was able to contain coronavirus cases due to timely and speedy testing with Allplex 2019-nCoV Assay, a testing kit by a Seoul based biotechnology firm, Seegene. Due to speedy testing, South Korea recorded 10284 cases and due to early detection, 6598 patients have successfully recovered. Therefore, it has eventually led to the flattening of the curve of infected patients.
Rapid point-of-care tests are also on the rise. Recently, Cepheid Xpert Xpress, a small portable device for quick screening has been launched. In addition finger prick test such as VivaCheck Biotech’s VivaDiag SARS-CoV-2 IgM/IgG rapid test is also a classic instance describing the rise in rapid testing measures. Such developments further augur the demand for diagnostic kits and will prove to be a boon for increasing the growth rate of the viral disease diagnosis market.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=62
The COVID-19 pandemic has increased the demand for diagnosis drastically. The World Health Organization (WHO) has also urged all the healthcare agencies to make the testing for COVID-19 pandemic a top priority. This, in turn, increases the demand for viral disease diagnosis testing. In addition, a blend of regulations and quick approvals by governments of various countries will also help the viral disease diagnosis market to a great extent.